I
Isabelle Soerjomataram
Researcher at International Agency for Research on Cancer
Publications - 201
Citations - 147827
Isabelle Soerjomataram is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 49, co-authored 166 publications receiving 83673 citations. Previous affiliations of Isabelle Soerjomataram include Erasmus University Rotterdam.
Papers
More filters
Journal ArticleDOI
Tobacco-related cancers in Europe: The scale of the epidemic in 2018.
Ivana Kulhánová,Ivana Kulhánová,David Forman,Jérôme Vignat,Carolina Espina,Hermann Brenner,Hans H. Storm,Linda Bauld,Isabelle Soerjomataram +8 more
TL;DR: Tobacco smoking was responsible for one in five cancer cases in Europe in 2018 and the introduction and robust implementation of tobacco control programmes are critical to reduce this cancer burden in the future.
Journal ArticleDOI
Does Alcohol Use Affect Cancer Risk
TL;DR: No threshold for the effects of alcohol on cancer has yet been identified, and thus, abstinence is best for cancer prevention and greater public awareness of the relationship between alcohol use and cancer is advisable.
Journal ArticleDOI
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
Sophie Pilleron,Hadrien Charvat,Marzieh Araghi,Melina Arnold,Miranda M Fidler-Benaoudia,Aude Bardot,Marianne Grønlie Guren,Hanna Tervonen,Alana Little,Dianne L. O'Connell,Anna Gavin,Prithwish De,Linda Aagaard Thomsen,Bjørn Møller,Christopher Jackson,Oliver Bucher,Paul M. Walsh,Sally Vernon,Freddie Bray,Isabelle Soerjomataram +19 more
TL;DR: Older patients diagnosed with localised (and in some countries regional) stage colon cancer who survived 6 months after diagnosis experienced the same survival as their younger counterparts, and increasing age was associated with lower net survival.
Journal ArticleDOI
Proportion of cancers attributable to major lifestyle and environmental risk factors in the Eastern Mediterranean region.
Ivana Kulhánová,Ariana Znaor,Kevin D. Shield,Kevin D. Shield,Melina Arnold,Jérôme Vignat,Maya Charafeddine,Ibtihal Fadhil,Heba Fouad,Amal Al-Omari,Ali Saeed Al-Zahrani,Amani El-Basmy,Ali Shamseddine,Freddie Bray,Isabelle Soerjomataram +14 more
TL;DR: It is estimated that approximately 33% (or 165,000 cases) of all new cancer cases in adults aged 30 years and older in 2012 were attributable to all selected risk factors combined.
Journal ArticleDOI
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Marzieh Araghi,Miranda Fidler-Benaoudia,Miranda Fidler-Benaoudia,Melina Arnold,Mark J. Rutherford,Aude Bardot,Jacques Ferlay,Oliver Bucher,Prithwish De,Gerda Engholm,Anna Gavin,Serena Kozie,Alana Little,Bjørn Møller,Nathalie St Jacques,Hanna E. Tervonen,Paul M. Walsh,Ryan Woods,Dianne L. O'Connell,David R Baldwin,Mark Elwood,Sabine Siesling,Freddie Bray,Isabelle Soerjomataram,Icbp Survmark Local Leads +24 more
TL;DR: One-year and 3-year age-standardised net survival (NS) was estimated by sex, histological type, stage and country in lung cancer cases as mentioned in this paper, showing that survival differences were also observed within stages, suggesting that quality of treatment, healthcare system factors and prevalence of comorbid conditions may also influence survival.